The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Multifunctional Au@AgBiS2 Nanoparticles as High‐Efficiency Radiosensitizers to Induce Pyroptosis for Cancer Radioimmunotherapy
Open accessAbstract
Radiotherapy (RT), a widely used clinical treatment modality for cancer, uses high‐energy irradiation for reactive oxygen species (ROS) production and DNA damage. However, its therapeutic effect is primarily limited owing to insufficient DNA damage to tumors and harmful effects on normal tissues. Herein, a core‐shell structure of metal–semiconductors (Au@AgBiS 2 nanoparticles) that can function as pyroptosis inducers to both kill cancer cells directly and trigger a robust anti‐tumor immune against 4T1 triple‐negative murine breast cancer and metastasis is rationally designed. Metal‐semiconductor composites can enhance the generation of considerable ROS and simultaneously DNA damage for RT sensitization. Moreover, Au@AgBiS 2, a pyroptosis inducer, induces caspase‐3 protein activation, gasdermin E cleavage, and the release of damage‐associated molecular patterns. In vivo studies in BALB/c mice reveal that Au@AgBiS 2 nanoparticles combined with RT exhibit remarkable antitumor immune activity, preventing tumor growth, and lung metastasis. Therefore, this core‐shell structure is an alternative for designing highly effective radiosensitizers for radioimmunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Synthesis, modification, and characterization of Au@AgBiS2. a) The synthesis process of the Au@AgBiS2. b–d) TEM images of the Au NRs, Au@ZnO, and Au@AgBiS2. e) HRTEM image of Au@AgBiS2. f–j) STEM images of Au@AgBiS2 and the elemental mappings of S, Bi, Au, and Ag, scale bars for g–j, 50 nm. k) UV–vis‐NIR absorbance spectra of Au, Au@AA‐[Zn(OH)4]2−, Au@ZnS, and Au@AgBiS2. l) XPS of the element peaks of Au@AgBiS2 and m) Bi 4f and S 2p peaks. n) XRD patterns of Au@AgBiS2. o) Zeta potentials and p) size distributions (n = 3) of Au@AgBiS2 and Au@AgBiS2‐PEG as determined by Malvern Zetasizer Nano ZS90.](/paper-figures/7e800e2f66b2487c8b4ba309526d1f1c/multifunctional-au-agbis-sub-2-sub-nanoparticles-as-highefficiency-figure-2.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This strategy promotes increased singlet oxygen production, mitochondrial dysfunction, oxidative injury, and apoptosis [39,40,68].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In RDT systems, X-ray irradiation activates radiosensitizing or photosensitizer-like components incorporated within nanoplatforms, resulting in active ROS generation through radiation-triggered photochemical processes [39,40,41,68].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hybrid and integrated nanoplatforms were widely reported, integrating multiple components within a single system. These platforms included metal–organic frameworks, organosilica nanoparticles, and composite structures combining metallic cores with catalytic, magnetic, or imaging elements [17,37,38,39,40,41].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Immune-modulating strategies, including checkpoint-related approaches, were described in combination with radiotherapy in selected nanoplatforms [17,21,23,26,39,56].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While ROS amplification and DNA damage remain the most consistently reported foundational processes [15,20,30,33,63], nanoplatforms combining physical dose enhancement with biologically active components, such as hypoxia-targeting systems, catalytic redox modulators, or immune-related approaches, demonstrate more robust and sustained antitumor effects across preclinical models [17,19,21,26,39,45,”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [39]
Experimental — accuracy not yet measured
19 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Semiconductor heterojunction photocatalysts: design, construction, and photocatalytic performances
Wang, H., Zhang, L., Chen, Z., Hu, J., Li, S., Wang, Z., Liu, J., & Wang, X. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00126e · Cited by 4,197
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., & Shao, F. (2017) · Nature · doi:10.1038/nature22393 · Cited by 3,199
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Vanpouille-Box, C., Alard, A., Aryankalayil, M. J., Sarfraz, Y., Diamond, J. M., Schneider, R. J., Inghirami, G., Coleman, C. N., Formenti, S. C., & Demaria, S. (2017) · Nature Communications · doi:10.1038/ncomms15618 · Cited by 1,834
Gasdermin E suppresses tumour growth by activating anti-tumour immunity
Zhang, Z., Zhang, Y., Xia, S., Kong, Q., Li, S., Liu, X., Junqueira, C., Meza-Sosa, K. F., Mok, T. M. Y., Ansara, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2071-9 · Cited by 1,686
A bioorthogonal system reveals antitumour immune function of pyroptosis
Wang, Q., Wang, Y., Ding, J., Wang, C., Zhou, X., Gao, W., Huang, H., Shao, F., & Liu, Z. (2020) · Nature · doi:10.1038/s41586-020-2079-1 · Cited by 1,083
Golden, E. B., Chhabra, A., Chachoua, A., Adams, S., Donach, M., Fenton-Kerimian, M., Friedman, K., Ponzo, F., Babb, J. S., Goldberg, J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00054-6 · Cited by 667
Wang, C., Cheng, L., & Liu, Z. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.069 · Cited by 666
Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Chen, Q., Chen, J., Yang, Z., Xu, J., Xu, L., Liang, C., Han, X., & Liu, Z. (2019) · Advanced Materials · doi:10.1002/adma.201802228 · Cited by 661
Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis
Zhou, B., Zhang, J.-Y., Liu, X.-S., Chen, H.-Z., Ai, Y.-L., Cheng, K., Sun, R.-Y., Zhou, D., Han, J., & Wu, Q. (2018) · Cell Research · doi:10.1038/s41422-018-0090-y · Cited by 660
Lu, K., He, C., Guo, N., Chan, C., Ni, K., Lan, G., Tang, H., Pelizzari, C., Fu, Y.-X., Spiotto, M. T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0203-4 · Cited by 596
Research works printed but not linked: 1
- 10.1002/anie.202204904 · DOI · Paper page
Cited by
Oxidative Stress and Cancer Therapy: Controlling Cancer Cells Using Reactive Oxygen Species
Ju, S., Singh, M. K., Han, S., Ranbhise, J. S., Ha, J., Choe, W., Yoon, K., Yeo, S. G., Kim, S. S., & Kang, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212387 · Cited by 148
Cuproptosis-Inducing Functional Nanocomposites for Enhanced and Synergistic Cancer Radiotherapy
Jiang, T., Jia, T.-Y., Yin, Y., Li, T., Song, X., Feng, W. J., Wang, S., Ding, L., Chen, Y., & Zhang, Q. (2025) · ACS Nano · doi:10.1021/acsnano.4c13753 · Cited by 69
New strategies for lung cancer diagnosis and treatment: applications and advances in nanotechnology
Feng, J., Zhang, P., Wang, D., Li, Y., & Tan, J. (2024) · Biomarker Research · doi:10.1186/s40364-024-00686-7 · Cited by 59
Qin, W., Qiao, L., Wang, Q., Gao, M., Zhou, M., Sun, Q., Zhang, H., Yang, T., Shan, G., Yao, W., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c09499 · Cited by 49
New Approaches in Radiotherapy
Webster, M. J., Podgorsak, A. R., Li, F., Zhou, Y., Jung, H., Yoon, J., Lemus, O. D., & Zheng, D. (2025) · Cancers · doi:10.3390/cancers17121980 · Cited by 57
Metadata
- Authors
- Xiao, L., Chen, B., Wang, W., Tian, T., Qian, H., Li, X., & Yu, Y.
- Affiliations
- Department of Radiology Research Center of Clinical Medical Imaging Anhui Province Clinical Image Quality Control Center The First Affiliated Hospital of Anhui Medical University Hefei Anhui 230022 P. R. China
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Corresponding author
- Qian, Haisheng
- Li, Xiaohu
- Yu, Yongqiang
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2023-09-08
- Volume
- 10
- Issue
- 30
- Pages
- e2302141-e2302141
- ISSN
- 2198-3844 (ISSN-L)
- PMC
- PMC10602534
- OpenAlex
- W4386564652
- Cited by
- 64
- References
- 55
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 24 · 2023: 3
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Advanced Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (52172276, U20A20379)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- core-shell nanoparticles, radiosensitizers, radioimmunotherapy, pyroptosis, metal-semiconductor composites, reactive oxygen species, DNA damage, caspase-3 activation, damage-associated molecular patterns, triple-negative breast cancer, lung metastasis, antitumor immunity, gold nanoparticles, silver bismuth sulfide
- MeSH terms
- Pyroptosis, Animals, Lung Neoplasms, Mice, Inbred BALB C, Radiation-Sensitizing Agents, Radioimmunotherapy, Reactive Oxygen Species, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multifunctional Au@AgBiS2 Nanoparticles as High‐Efficiency Radiosensitizers to Induce Pyroptosis for Cancer Radioimmunotherapy. https://app.cochat.ai/papers/10.1002/advs.202302141
- The paper
- Xiao, L., Chen, B., Wang, W., Tian, T., Qian, H., Li, X., & Yu, Y. (2023). Multifunctional Au@AgBiS2 Nanoparticles as High‐Efficiency Radiosensitizers to Induce Pyroptosis for Cancer Radioimmunotherapy. Advanced Science. https://doi.org/10.1002/advs.202302141
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.